|
Others | | | | | | |  | (1S,4S)-(+)-2,5-Diazabicyclo[2.2.1]heptane dihydrobromide 97% | C5H10N2 · 2HBr | 473006 | pricing | |  | (1S,4S)-2,5-Diazabicyclo[2.2.1]heptane dihydrobromide purum, ≥98.0% (AT) | C5H10N2 · 2HBr | 33472 | pricing | |  | D-Mannose 6-sulfate sodium salt ≥90% (TLC) | C6H11NaO9S | 14652 | pricing | |  | (2R,5S)-2-Trichloromethyl-3-oxa-1-azabicyclo[3.3.0]octan-4-one purum, ≥98.0% (AT) | C7H8Cl3NO2 | 42134 | pricing | |  | (+)-6-Aminopenicillanic acid BioChemika, ≥98.0% (S) | C8H12N2O3S | 09070 | pricing | |  | (+)-6-Aminopenicillanic acid 96% | C8H12N2O3S | A70909 | pricing | |  | (R)-(+)-1,2-Dithiolane-3-pentanoic acid 97% | C8H14O2S2 | 579602 | pricing | |  | Sepiapterin solid | C9H11N5O3 | S154 | pricing | |  | D-(+)-Neopterin ≥97.5% (sum of enantiomers, HPLC) | C9H11N5O4 | N3386 | pricing | |  | D-(+)-Neopterin BioChemika, ≥97.5% (sum of enantiomers, HPLC) | C9H11N5O4 | 72147 | pricing | |  | (3R-cis)-(−)-2,3-Dihydro-3-isopropyl-7a-methylpyrrolo[2,1-b]oxazol-5(7aH)-one 98% | C10H15NO2 | 458546 | pricing | |  | (3S-cis)-(+)-2,3-Dihydro-3-isopropyl-7a-methylpyrrolo[2,1-b]oxazol-5(7aH)-one 98% | C10H15NO2 | 458554 | pricing | |  | (3S-cis)-(+)-Tetrahydro-3-isopropyl-7a-methylpyrrolo[2,1-b]oxazol-5(6H)-one 95% | C10H17NO2 | 334235 | pricing | |  | (1S,4S)-(−)-2-Boc-2,5-diazabicyclo[2.2.1]heptane 95% | C10H18N2O2 | 473049 | pricing | |  | (1S,4S)-(−)-2-(4-Chlorophenyl)-2,5-diazabicyclo[2.2.1]heptane hydrobromide | C11H13ClN2 · HBr | 473391 | pricing | |  | (1S,4S)-(−)-2-(3-Fluorophenyl)-2,5-diazabicyclo[2.2.1]heptane hydrobromide | C11H13FN2 · HBr | 473405 | pricing | |  | (1S,4S)-(−)-2-(4-Fluorophenyl)-2,5-diazabicyclo[2.2.1]heptane hydrobromide | C11H13FN2 · HBr | 473367 | pricing | |  | (S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione 99% | C12H12N2O2 | 340650 | pricing | |  | (1S,4S)-(+)-2-Benzyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide 99% | C12H16N2 · 2HBr | 473030 | pricing | |  | (1S,4S)-(−)-2-(4-Methylphenyl)-2,5-diazabicyclo[2.2.1]heptane maleate salt 95% | C12H16N2 · C4H4O4 | 495271 | pricing | |  | (2R,4R)-(+)-4,5-Dihydro-4-isopropyl-2-(p-tolyl)-1,2λ4,3-oxathiazole 2-oxide 98% | C12H17NO2S | 648337 | pricing | | | | (2S,4S)-4,5-Dihydro-4-isopropyl-2-(p-tolyl)-1,2λ4,3-oxathiazole 2-oxide 98% | C12H17NO2S | 648345 | pricing | |  | (3R-cis)-(−)-2,3-Dihydro-7a-methyl-3-phenylpyrrolo[2,1-b]oxazol-5(7aH)-one 98% | C13H13NO2 | 458562 | pricing | |  | (3S-cis)-(+)-2,3-Dihydro-7a-methyl-3-phenylpyrrolo[2,1-b]oxazol-5(7aH)-one 98% | C13H13NO2 | 458570 | pricing | |  | Benzyl (S,S,S)-2-azabicyclo[3.3.0]octane-3-carboxylate hydrochloride 97% | C15H19NO2 ·HCl | 570907 | pricing | |  | (+)-N-(1(S)-Phenylethyl)-1-azabicyclo[2.2.2]octan-3(R)-amine hydrochloride 98% | C15H22N2 · 2HCl | 510343 | pricing | |  | (−)-N-(1(R)-Phenylethyl)-1-azabicyclo[2.2.2]octan-3(S)-amine dihydrochloride 98% | C15H22N2 · 2HCl | 487244 | pricing | |  | Aloperine 96% | C15H24N2 | 546704 | pricing | |  | (2S-cis)-(+)-2,3-Dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one 98% | C16H15NO3S | 475548 | pricing | |  | (−)-Scopolamine hydrobromide trihydrate purum, ≥98.0% (TLC) | C17H21NO4 · HBr · 3H2O | 84785 | pricing | |  | (3S-cis)-(+)-Tetrahydro-3,7a-diphenylpyrrolo[2,1-b]oxazol-5(6H)-one 98% | C18H17NO2 | 458538 | pricing | |  | Ergotamine D-tartrate purum, ≥97.0% (calc. based on dry substance, NT) | C33H35N5O5 · 0.5C4H6O6 | 45510 | pricing | |  | Ergotamine D-tartrate Ph Eur | C33H35N5O5 · 0.5C4H6O6 | 45512 | pricing | | |
|